Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer

BACKGROUND: Breast cancer (BC) is the most common cancer in women, and despite the introduction of new screening programmes, therapies and monitoring technologies, there is still a need to develop more useful tests for monitoring treatment response and to inform clinical decision making. The purpose...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res
Autors principals: Fernandez-Garcia, Daniel, Hills, Allison, Page, Karen, Hastings, Robert K., Toghill, Bradley, Goddard, Kate S., Ion, Charlotte, Ogle, Olivia, Boydell, Anna Rita, Gleason, Kelly, Rutherford, Mark, Lim, Adrian, Guttery, David S., Coombes, R. Charles, Shaw, Jacqueline A.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6924016/
https://ncbi.nlm.nih.gov/pubmed/31856868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1235-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars